Skip to content
Open access · CC-BY via OpenAlex

Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline

Muhammad Shafique Khan, Mengyu Liu, Aymen Safdar, Mehreen Malik, Khalid Jamaan Alzahrani, Khalaf F. Alsharif, Fuad M. Alzahrani, Ataullah Khan, Shahid Hussain, Chien-Chin Chen

Stem Cell Research & Therapy · 2026

Abstract

Aging is a complex, multifactorial biological process marked by progressive physiological decline and increased vulnerability to chronic disease. Advances in geroscience have expanded the telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition) into twelve interrelated mechanisms categorized as primary, antagonistic, and integrative. Emerging biological therapies—including mesenchymal stem cell (MSC) therapies, stem cell-derived extracellular vesicles (EVs), monoclonal antibodies (mAbs), and plasma-based approaches—do not map onto these hallmarks in simple one-to-one relationships; rather, they exert pleiotropic effects across systemic inflammatory, metabolic, and regenerative networks. This review compiles current evidence on emerging biological treatments, highlighting early-phase immunomodulatory effects, cell-free alternatives for matrix remodeling, precision inflammatory control via mAbs, and systemic circulating signals. Despite promising preclinical and early clinical findings, translational challenges—including safety validation, production standardization, scalability, and long-term efficacy—must be addressed to establish mechanism-based anti-aging interventions.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s13287-026-05287-9
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Khan, M.S., Liu, M., Safdar, A., Malik, M., Alzahrani, K.J., Alsharif, K.F., Alzahrani, F.M., Khan, A., Hussain, S., &amp; Chen, C. (2026). Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline. <em>Stem Cell Research & Therapy</em>. https://doi.org/10.1186/s13287-026-05287-9
Vancouver
Khan MS, Liu M, Safdar A, Malik M, Alzahrani KJ, Alsharif KF, et al. Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline. Stem Cell Research & Therapy. 2026. doi:10.1186/s13287-026-05287-9.
BibTeX
@article{muhammad2026Emergi, title = {Emerging biological therapies for healthy aging: targeting inflammaging, senescence, and regenerative decline}, author = {Muhammad Shafique Khan and Mengyu Liu and Aymen Safdar and Mehreen Malik and Khalid Jamaan Alzahrani and Khalaf F. Alsharif and Fuad M. Alzahrani and Ataullah Khan and Shahid Hussain and Chien-Chin Chen}, journal = {Stem Cell Research & Therapy}, year = {2026}, doi = {10.1186/s13287-026-05287-9}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings